CAGRISEMA is a dual-peptide research blend combining Cagrilintide (amylin analog) and Semaglutide (GLP-1 receptor agonist), widely studied for its role in appetite regulation signaling, metabolic efficiency pathways, and glucose homeostasis mechanisms
Indcued increase of growth hormone receptor in tendon fibroblasts may potentiate the proliferation-promoting effect of growth hormone and contribute to the healing effects of BPC-157
This protective function may help maintain skin elasticity, reduce the appearance of fine lines, and promote an overall healthier complexion
Contrary to certain claims, BPC-157 is a safe and effective healing agent, known colloquially as the Wolverine drug for its potent regenerative abilities
Personalized Precision Therapy to Overcome Plateaus The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO, and MC4R variants that relate to GLP-1 and related signaling pathways